Inovio Pharmaceuticals Inc (INO)

[erdos47]

J and J and Astrazeneca used old technology to quickly bring emergency use products to market. In the past there was much more risk tolerated, and probably unknown by the public, such as the bad batch of polio vaccine but the public still wanted to be treated compared to risking the disease. Now that mRNA has proved to be so effective in hundreds of millions of doses with no bad outcomes, the public and the agencies will be much more interested in using new technology even though they were used without full approval but just EUA. Due to the benefits of DNA vaccine candidates that are more stable, there should soon be serious consideration to support for this new strategy. Adenovirus vaccine will be obsolete once a DNA vaccine gets EUA so that millions of doses can be rolled out.